Kalorama Information is the authoritative market research source for the diagnostics industry. Find essential insights, market shares, sales segmentation and projections for in vitro diagnostics (IVD) and medical imaging markets. Kalorama’s reports, including The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th edition, analyze the global in vitro diagnostics market, now worth approximately $83.3 billion. Our diagnostics market research covers trends in health care service delivery, including the rapidly advancing diagnostic laboratory technology industry. Discover emerging diagnostics market niches in our updated reports that present the trends, technologies, customer needs, and major suppliers currently shaping the diagnostics industry.
Molecular Assays
Point-of-Care
Immunoassays
Infectious Disease
Clinical Chemistry
Oncology/Hematology
Lab Testing Services
Medical Imaging
- Display 45 Products per page
Published: November 10, 2014 | Price: $995.00 – $1,990.00
X-Ray: World Market Analysis Medical imaging has led to improvements in the diagnosis and treatment of numerous medical conditions in children and adults. There are many types of medical imaging procedures, each of which uses different technologies and techniques. Medical radiography (conventional x-ray, including mammography) is a term that covers several types of studies that require the visualization of the internal parts of the body using x-ray techniques. This report, X-Ray: World Market Analysis, analyzes the current and potential world...Published: December 1, 2010 | Price: $2,800.00 – $5,990.00
Diagnostic tests performed outside the central laboratory or decentralized testing is generally known as point-of-care (POC). Over the years, the increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and most recently, convenience clinics. Moreover POC test devices have contributed significantly to the growth of the overall diagnostics market over the past 10 years. As more diagnostic...Published: November 1, 2006 | Price: $1,500.00 – $5,990.00
This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There is also an emphasis on early disease detection via rapid test use in clinics and public venues. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place. The field for rapid test devices is crowded; worldwide,...Published: February 3, 2017 | Price: $3,196.00 – $6,392.00
The World Market for Point of Care (POC) Diagnostics World Market for Point of Care (POC) Diagnostics examines the worldwide market for POC, including the following information: Worldwide POC Test Market for every significant segment of POC Testing from 2014-2021; Worldwide POC Market Share of top manufacturers, 2016; Professional and Self-testing, 2016; Worldwide POC professional testing analysis by product subcategory, 2016; POC testing revenues in US, Europe, Japan, and the rest of the world, 2016; POC market revenues for Germany,...Published: November 7, 2018 | Price: $5,500.00 – $11,000.00
World Market for Precision Cancer Diagnostic Tests Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves. These tests are also used in cancer staging as well as in the selection, monitoring, and assessment of prescribed oncological therapies. World Market for Precision Cancer Diagnostic Tests, a market-based and industry-focused report, examines the global market environment for precision cancer testing products and procedures, including the following...Published: January 9, 2013 | Price: $4,500.00 – $9,000.00
Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market. As analyst Shara Rosen, R.T., MBA. details, in recent years years the number of assays introduced has been growing at a remarkable clip. This report, The World Market for Molecular Diagnostics (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) represents the fifth time that Kalorama has conducted a complete study into the market for molecular diagnostics. Comprehensive Coverage...Published: March 1, 2011 | Price: $150.00 – $300.00
This report The World Market for Molecular Diagnostics: Potential and Reality, What's Hot and What's Not estimates the market for molecular diagnostics and provides a realistic look at the role of molecular testing and its future in various market segments. Kalorama Information's lead diagnostics analyst Shara Rosen, R.T., MBA, also reviews the competitors in the market and their latest moves. There have been many predictions made about a molecular revolution in diagnostics. Indeed some are now taking place, while other...Published: January 1, 2009 | Price: $3,995.00 – $7,990.00
Molecular diagnostics represents a revolution postponed, perhaps, but one that is now clearly underway. DNA Testing has emerged fully from research into clinical practice and becoming a dominant platform in clinical medicine. From Emerging to Emergent Technology Instrumentation now automates many of the sample preparation and assay steps that were formerly labor intensive. New tests are being launched all the time. At each step of the way, Kalorama Information has reported on its progress, and in this latest market research...Published: October 18, 2023 | Price: $6,000.00 – $12,000.00
Laboratory information systems (LIS), also known as laboratory information management systems (LIMS), are data and information management systems designed for industrial and healthcare-related laboratories, including clinical and analytical laboratories. These include research and development labs, in-process testing labs and quality assurance labs. This new report from Kalorama Information, World Market for Laboratory Information Systems (LIS): Software, Hardware, and Implementation for Clinical Labs, 2022-2027, examines the current and potential world opportunity for healthcare laboratory information system (LIS) software, hardware, and implementation....Published: October 5, 2017 | Price: $2,800.00 – $5,600.00
World Market for Infectious Disease Immunoassays This report contains important business data for the infectious disease immunoassay, market, a high-growth area of immunoassy IVD testing. The report contains: Global Lab-based Infectious Disease Immunoassay Market Sizing for the following infection types: Hepatitis HIV STD TORCH Respiratory HAIs Other Infectious Disease Kalorama Information's report, The World Market for Infectious Disease Immunoassays, provides important business planning data for companies in the immunoassay market, investing in the field, or considering expansion. The following are...Published: January 7, 2022 | Price: $3,750.00 – $7,500.00
It’s estimated that cardiovascular diseases, including those of the blood vessels supplying the heart muscle and the brain, are the leading cause of death globally. With the incidence of cardiovascular disease going through the roof, Kalorama Information’s report, World Market for Cardiac Markers (POC and Lab-Based), covers why cardiac markers are in huge demand and a constant subject of research for improvement. Cardiac biomarkers are substances that are released into the bloodstream when the heart is damaged or stressed. In...Published: January 1, 2012 | Price: $1,995.00 – $4,995.00
This Kalorama Information report - The World Market for Cancer Therapeutics and Biotherapeutics (Chemotherapy Agents, Interleukins/interferons, Monoclonal Antibodies, Hormone and Other Therapies) represents the fourth time that Kalorama Information has taken a comprehensive look at oncology therapeutics. The report focuses on several segments for cancer treatment including: Chemotherapy, - Subcategories include Alkylating Agents, Antimetabolites, Cytotoxic Agents, Plant Derivatives - Brands such as Elotaxin, Taxotere, Gemzar, Alimta and Temodar, with Market Share for each Hormone Therapy: - Subcategories include Corticosteroids, Hormone...Published: November 22, 2021 | Price: $9,000.00 – $12,000.00
Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence. The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity assessment. Segment markets for cancer testing are comprehensively covered in Kalorama Information’s World Market for Cancer Diagnostics. ...Published: January 5, 2022 | Price: $3,750.00 – $7,500.00
This new Kalorama Information report, World Market for Blood Screening, focuses on the evolving, multibillion dollar global blood screening market. Blood screening is a medical process that scans the blood for infectious diseases or conditions. In developed nations, donated blood is screened for various pathogens. It is a mature market; however, growth comes from new technologies, increased volume and increased testing in developing nations. Blood screening testing’s primary objectives are to monitor the appearance of newly discovered infectious agents in...Published: January 22, 2016 | Price: $3,600.00 – $6,320.00
This Kalorama Information In Vitro Diagnostics (IVD) Market Bundle represents three reports, as published in 2015. These reports, representing over 2,000 pages of market information, delve into some of the fastest-growing and most critical areas of clinical diagnostics: cancer diagnostics, molecular assays and systems, and infectious disease tests. Together, these three in vitro diagnostic areas represent nearly one-half of the IVD market and the best growth opportunities. The Bundle features the exact published content in each of the three major Kalorama...Published: April 1, 2009 | Price: $1,500.00 – $9,990.00
From Kalorama Information a unique tool for assessing the diagnostic business today. Working in conjunction with premier diagnostic survey database Emmes Group, Kalorama Information presents the summarized results from a recent survey of a critical mass of diagnostic labs in the U.S, with analysis from Kalorama's leading diagnostic analyst, Shara Rosen. Far more than any other market research report, this report provides the most current and accurate picture of what is truly going on in molecular diagnostics in the United...Published: May 26, 2017 | Price: $200.00 – $400.00
This report describes major trends in the in vitro diagnostic industryPublished: March 22, 2017 | Price: $200.00 – $400.00
Kalorama's current trends in the in vitro diagnostic industry.Published: June 23, 2017 | Price: $400.00 – $800.00
Published: February 22, 2017 | Price: $200.00 – $400.00
Monthly events of note in the in vitro diagnostic industry from Kalorama Information's analysts.Published: April 24, 2017 | Price: $200.00 – $400.00
A look at key trends in in vitro diagnostics in the month of April 2017.Published: July 1, 2009 | Price: $995.00 – $1,900.00
As Kalorama Information has examined the markets for year, we have seen the companies whose approaches have succeeded and those who have not been successful. A small pivot in strategy often may have made the difference. We have summed up this knowledge in What is Working in IVD: Successful Commercialization of New Products and Technologies The report is written by Kalorama's lead diagnostic expert, Shara Rosen, R.T. M.B.A., author of six best-selling editions of the industry's leading market research report...Published: October 1, 2009 | Price: $995.00 – $1,990.00
Diagnostic tests are an essential tool for confirming the health status of animals. The global impact of diseases such as bovine spongiform encephalopathy, foot and mouth disease, and highly pathogenic avian influenza has revealed that diagnostic tests play a key role not only in facilitating safe trade but also in many other areas such as the early detection of new diseases and the control of exotic or enzootic animal diseases. The market emerged from nascence in the early 2000s and...Published: February 1, 2011 | Price: $150.00 – $300.00
This report covers the U.S. market for Picture Archiving and Communication Systems (PACS) and provides an overview of imaging systems, EMR and PACS technologies and products. The report describes the industry, its relationship to various healthcare channels, and the trends for the future. The report addresses some of the issues surrounding IT in healthcare and how the PACS arena is affected by these issues. While Kalorama Information has studied EMR markets in great detail in other reports, this report does...Published: June 27, 2016 | Price: $3,196.00 – $6,720.00
United States Market for In Vitro Diagnostic Tests United States Market for In Vitro Diagnostic Tests takes a considered look at the U.S. in vitro diagnostics (IVD) market and examines what current market trends mean for diagnostic manufacturers and investors. This report includes important tools for business planners. Included are market size estimates and forecasts for the following U.S. IVD segments: Clinical Chemistry Market (2015/2020) Identification and Antibiotic Susceptibility Testing (ID/AST) Microbiology (Traditional) Market – Automated ID/AST, Manual/Semi‐Auto ID/AST, Blood...Published: October 6, 2022 | Price: $5,000.00 – $10,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, discusses the trends shaping the present and future of the IVD...Published: June 7, 2021 | Price: $4,000.00 – $8,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...Published: July 19, 2019 | Price: $6,500.00
Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Information report is an essential tool to learn how the in vitro diagnostics industry is seen from the point of view of their customers. Kalorama conducted a 2019 survey of laboratory instrument users in the United States, Canada and Europe (included in respondents are lab managers, lab directors,...Published: December 17, 2014 | Price: $995.00 – $1,990.00
Ultrasound: World Market Analysis Medical imaging has led to improvements in the diagnosis and treatment of numerous medical conditions in children and adults. There are many types of medical imaging procedures, each of which uses different technologies and techniques. Ultrasound is defined as energy generated by sound waves of 20,000 or more vibrations per second, with a frequency greater than the upper limit of the human hearing range. Knowledge of the harmful effects of radiation exposure continues to promote the...Published: November 15, 2004 | Price: $4,995.00 – $9,990.00
This unprecedented study provides detailed market data on products and segments in the retail OTC diagnostic market in the United States. In addition to market size, growth and competitive share information on each of six testing categories plus testing accessories, the report contains the results of a major consumer survey conducted jointly by Kalorama Information and The Telephone Centre, Inc., focusing on consumer attitudes and awareness of OTC testing products and their marketing channels. This valuable consumer information, never before...Published: May 1, 2004 | Price: $3,500.00 – $7,000.00
Molecular diagnostics are seen as being a major breakthrough in medical science. While the technology itself has broad applications to such areas as agricultural bioterrorism and environmental science, medical and medical research applications have provided the primary focus. As a result, great things have been predicted for the development and use of new therapeutics based on molecular testing approaches. The primary molecular diagnostics approaches are based on two major database sciences (genomics and proteomics) and their relationship to disease and...Published: January 8, 2018 | Price: $2,995.00 – $5,990.00
Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)Tumor Markers Immunoassay Market analyzes the current world market, including tumor markers immunoassay revenues by marker, 2015-2025 (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others, Total); regional revenues for tumor markers immunoassays, 2015-2025 (US, EU, ROW, Total); attributes of selected tumor marker immunoassays (cancer type, tissue analyzed, how used); and selected...Published: April 28, 2017 | Price: $2,000.00 – $4,000.00
Successful solid organ and hematopoietic stem cell (HSCT) or bone marrow transplants require histocompatibility between the recipient and donor. Molecular Technologies can be of assistance in this process. Autologous transplantation using hematopoietic cells from the same patient (donor and recipient) is increasingly common and eliminates the need to screen for histocompatibility. However, solid organ transplants and HSCT allografts from another donor requires histocompatibility confirmed by human leukocyte antigen (HLA) testing outside of genetically identical twins. This report, Transplant Matching Molecular...Published: May 4, 2017 | Price: $2,800.00 – $5,600.00
The POC market is considered evolving with growthopportunity.  Developing and developedmarkets alike have room to grow due to an aging population worldwide. Key companies such as Roche, LifeScan,Abbott, and Alere will likely maintain leading positions in the market throughcontinued product innovation and strategic alliances and mergers.  This report profiles 50 companies that will determine the future of POC testing, and also provides market sizing and forecast for: • The Global Point-of-Care Market, 2016-2021 • The Global POC Market by Testing...Published: April 10, 2018 | Price: $4,500.00 – $9,000.00
The Worldwide Microbiology Market (Traditional Microbiology, Microbiology/Infectious Disease Immunoassays, Molecular Microbiology, Mass Spectrometry in Microbiology) Microbiology has always been a major segment of the diagnostic market because the burden of infectious diseases is high. This important field is attracting even more attention today as the because of the large and growing problem of antibiotic resistance. The Worldwide Microbiology Market provides current market (2017) and market projections (to 2022) by segment (traditional microbiology, microbiology/infectious disease immunoassays, molecular microbiology, mass spectrometry in...Published: February 16, 2018 | Price: $3,995.00 – $7,990.00
What is the Size of the Point of Care Diagnostic Testing Market? This report provides an in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will...Published: March 27, 2019 | Price: $5,000.00 – $10,000.00
Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to a range of medical environments including the workplace, home, disaster care and, most recently, convenience clinics. Kalorama’s Worldwide Market...Published: March 17, 2020 | Price: $5,500.00 – $11,000.00
This report represents the 7th edition of a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to...Published: April 28, 2022 | Price: $6,000.00 – $12,000.00
As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations...Published: April 13, 2021 | Price: $5,000.00 – $10,000.00
By the middle of the decade, point of care testing is expected to reach 45 billion dollars annually. This should not be surprising. Globally, millions of dollars are spent annually on POC diagnostic testing, both professional testing and self-testing. In 2020, sales of POC testing reached $29,316 million. COVID-19 was a significant game changer in 2020. The number of new tests for POC COVID-19 was stunning. Updated for COVID-19 Impacts In some segments, COVID-19 caused a contraction of the segment...Published: April 23, 2024 | Price: $7,000.00 – $14,000.00
NOW IN ELEVEN EDITIONS—The Worldwide Market for Point-of-Care (POC) Diagnostic Tests forecasts the POC market through 2028. Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide meaningful results during a provider visit or in the patient's home. Over the past two decades, Kalorama Information has observed that POC tests present significant...Published: April 13, 2023 | Price: $6,000.00 – $12,000.00
The point-of-care diagnostics market has long been the opportunity market within IVD. Kalorama publishes a full-scope market research study annually on point of care (POC) devices that can test near the patient for maximum benefit to healthcare encounters. While tests run on lab-based analyzers, remain the bedrock of IVD revenues, point of care has always been seen as the growth area. There are more companies in the point of care market, and it is a top segment of investment. Now...Published: December 29, 2023 | Price: $5,000.00 – $10,000.00
Liquid biopsies have emerged as a minimally invasive diagnostic tool, analyzing tumor-derived materials circulating in biological fluids to offer valuable information for cancer diagnosis, treatment, and monitoring. While tissue biopsies and imaging techniques remain standard in solid tumor diagnosis, liquid biopsies present an alternative or complementary approach, addressing some of the limitations and risks associated with traditional methods. Key applications of liquid biopsy testing in clinical oncology include: Early Detection and Diagnosis/Screening: Identifying cancer at an early stage. Alternative Testing...Published: September 27, 2017 | Price: $3,600.00 – $7,200.00
The Market for Lab-Developed Test Services and the Market for Instruments and Reagents Sold to Labs This is a unique report with a unique segmentation to help customers find the right segment for their needs. Two separate but related markets are discussed in this report: the market for clinical laboratory services using laboratory developed tests, and the market for products (platforms and consumables) sold to clinical laboratories who uses these products to make LDTs. Both are large and rapidly...Published: September 24, 2020 | Price: $5,500.00 – $11,000.00
Laboratory developed tests (LDTs) are not a new or recent phenomenon but due to the incredible need for testing of SARS-CoV-2, there has been a flood of new tests and the regulatory guidance has changed dramatically. Historically, these tests were called “home-brew tests” or “in-house tests.” Also, historically, these tests were low-volume, simple and well characterized tests for low-risk diagnostic applications. Today, high-risk, complex tests have been developed as LDTs, and are being used to provide clinical results to physicians...